GlassScriptPhysician profile
Rucheet Patel
NPI 1861711681
$2,440.04
in general payments reported to CMS, 2019-2025
21 companies · $851 in 2025
The $851 reported for 2025 was more than what 86% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $25.13 · 2021: $75.00 · 2022: $351 · 2023: $469 · 2024: $496 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.22 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $597.63 | 2019-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $288.92 | 2019-2025 | Nucala |
| Jazz Pharmaceuticals INC. | $253.68 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $247.40 | 2019-2025 | Dupixent |
| Genzyme Corporation | $200.46 | 2019-2025 | |
| Harmony Biosciences LLC | $180.87 | 2022-2025 | |
| Amgen INC. | $123.35 | 2023 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $81.47 | 2023-2025 | Lumryz |
| Covis Pharma Gmbh | $72.18 | 2019-2021 | |
| Baxter Healthcare | $65.79 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Azurity Pharmaceuticals, INC. | $62.97 | 2025 | Alvesco |
| Electromed, INC. | $59.38 | 2019-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $54.50 | 2022-2025 | |
| Ars Pharmaceuticals Operations, INC. | $29.91 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $26.36 | 2024 | Cuvitru |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $20.36 | 2025 | Inspire |
| Organon LLC | $16.94 | 2025 | |
| Phadia US INC. | $16.03 | 2021 | |
| Genentech USA, INC. | $15.21 | 2022 | |
| Fisher & Paykel Healthcare INC | $13.81 | 2019 | |
| Alk-Abello, INC | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rucheet Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.